(S)-Modafinil, identified by CAS number 112111-47-4, is a chemical compound of significant interest in pharmaceutical research and development. With a molecular formula of C15H15NO2S and a molecular weight of 273.35, it represents a precise molecular structure crucial for targeted therapeutic effects. NINGBO INNO PHARMCHEM CO.,LTD. offers this high-quality intermediate, recognizing its importance in the synthesis of various pharmaceutical products, particularly those aimed at modulating wakefulness and cognitive states.

The chemical synthesis of enantiomerically pure compounds like (S)-Modafinil is a complex but essential process in drug discovery. Our manufacturing expertise ensures that the product adheres to strict specifications, making it a reliable component for creating sophisticated APIs. The pharmaceutical intermediate market demands materials that are not only pure but also consistently available, which is a commitment NINGBO INNO PHARMCHEM CO.,LTD. upholds.

The applications for (S)-Modafinil extend beyond basic research. It serves as a critical precursor in the creation of medications designed to treat conditions characterized by excessive daytime sleepiness. The development of such pharmaceuticals requires a deep understanding of chemical pathways and the precise action of each component. By providing a high-quality (S)-Modafinil, we empower researchers to explore new therapeutic avenues and refine existing treatments, contributing to advancements in patient care.

For companies in the pharmaceutical sector looking to buy (S)-Modafinil, partnering with NINGBO INNO PHARMCHEM CO.,LTD. offers distinct advantages. We are a trusted manufacturer in China, known for our commitment to quality control and customer service. Our ability to supply (S)-Modafinil reliably supports the continuous flow of production and innovation in the pharmaceutical industry. We encourage you to reach out to us to learn more about the technical specifications and bulk purchase options for (S)-Modafinil, a key element in your next pharmaceutical breakthrough.